Shield Therapeutics (STX) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free STX Stock Alerts GBX 1.55 -0.10 (-6.06%) (As of 05/3/2024 05:07 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShield Therapeutics (LON:STX) Trading Down 11.1%americanbankingnews.com - May 5 at 2:00 AMGalera Therapeutics Implements Stockholder Rights Plan to Shield Investor Interestsmsn.com - May 3 at 11:19 PMShield Therapeutics (LON:STX) Trading Up 17.6%americanbankingnews.com - May 3 at 5:20 AMTurning a tumor's 'shield' into a weapon against itselfmsn.com - May 2 at 1:18 PMNeutral Switzerland joins European Sky Shield defence projectmsn.com - April 10 at 7:15 AMAmerican Home Shield Offering 40% Off ShieldGold™ For Limited Timetmcnet.com - April 1 at 3:14 PMA Real Life Invisibility Shield for Privacy in Public Placesmsn.com - March 29 at 4:58 PMSeal Shield to Showcase Shyld AI, the World's First Intelligent, Autonomous, UV-C Disinfection System at HIMSS 2024tmcnet.com - March 11 at 10:35 AMLONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minuteslse.co.uk - February 23 at 4:14 PMShield Therapeutics PLC STXmorningstar.com - February 22 at 2:15 PMShield Therapeutics plc (STX.L)uk.finance.yahoo.com - February 13 at 7:26 PMShield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years agofinance.yahoo.com - January 24 at 4:20 AMShield Therapeutics plc (LON:STX) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - December 28 at 9:53 AMShield Therapeutics to present at NPWH conference this monthproactiveinvestors.com - October 20 at 9:58 AMShield Therapeutics CFO Hans-Peter Rudolf to Step Downmarketwatch.com - October 12 at 9:11 AMShield Therapeutics launches executive search process as CFO steps downproactiveinvestors.com - October 12 at 9:11 AMShield Therapeutics "couldn't be more pleased" with Viatris collaborationfinance.yahoo.com - October 5 at 7:44 AMShield Therapeutics' pricing will be "key metric" - Proactive Research Analystfinance.yahoo.com - October 5 at 7:44 AMShield Therapeutics secures debt facility, retail share offer closes soonproactiveinvestors.com - October 3 at 5:49 AMShield Therapeutics First Half 2023 Earnings: US$0.025 loss per share (vs US$0.069 loss in 1H 2022)finance.yahoo.com - September 30 at 7:42 AMShield Therapeutics hails progress in Stateside venture as losses narrowmsn.com - September 29 at 10:05 AMShield Therapeutics Shares Fall After Discounted Equity Raisemarketwatch.com - September 28 at 8:20 AMPrivate companies who hold 41% of Shield Therapeutics plc (LON:STX) gained 17%, institutions profited as wellfinance.yahoo.com - September 5 at 6:53 AMShield Therapeutics : First signs of hoped-for Accrufer Rx inflectionproactiveinvestors.com - July 29 at 6:37 AMHardman & Co Research on Shield Therapeutics (STX): Accrufer Rx momentum gatheringfinanznachrichten.de - July 25 at 10:39 AMShield Therapeutics "really starting to fire on all cylinders"finance.yahoo.com - July 25 at 10:39 AMShield Therapeutics Shares Rise as US Prescriptions for Accrufer Soarmarketwatch.com - July 20 at 2:17 PMShield Therapeutics makes waves in US as iron deficiency prescriptions ramp upmsn.com - July 20 at 9:17 AMShield Therapeutics reports 173% Accrufer prescription growthproactiveinvestors.com - July 20 at 9:17 AMSave $30 on the Nvidia Shield Android TV for Amazon Prime Daymsn.com - July 11 at 10:14 PMNeutral Swiss join Europe's Sky Shield defencemsn.com - July 7 at 11:24 AMSwiss Want In On Germany's Sky Shield Planbarrons.com - July 4 at 4:01 PMHardman & Co Research on Shield Therapeutics (STX): Reassuring 1Q’23 Accrufer prescriptionsuk.movies.yahoo.com - May 17 at 8:54 AMShield Therapeutics directors urge rejection of mandatory offerproactiveinvestors.com - May 4 at 4:28 PMShield Therapeutics well positioned with "great partnership" - Proactive Research Analystproactiveinvestors.com - May 2 at 3:17 PMShield Therapeutics ready to go full throttle in the USproactiveinvestors.com - April 27 at 7:59 AMShield Therapeutics appoints chief commercial officer as group readies for US sales offensiveproactiveinvestors.com - April 5 at 8:50 AMLoss-Making Shield Therapeutics plc (LON:STX) Expected To Breakeven In The Medium-Termfinance.yahoo.com - March 27 at 8:33 AMShield Therapeutics "ended 2022 in a very very productive state"finance.yahoo.com - February 13 at 11:02 AMProactive research analyst says Shield Therapeutics "in fast growth mode"finance.yahoo.com - February 13 at 11:02 AMPrivacy Shield: The Six Things You Need to Know That Might Affect Your Companybenzinga.com - February 9 at 2:39 PMShield Therapeutics primed for a strong year as it confirms plans to become self-sufficientproactiveinvestors.com - February 9 at 8:51 AMShield Therapeutics shares jump 13%; broker sets punchy price targetproactiveinvestors.com - February 9 at 8:51 AMHardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capitalmarkets.businessinsider.com - January 23 at 8:06 AMHardman & Co Research: Shield Therapeutics (STX) - Positioned for growth and profitabilityuk.finance.yahoo.com - January 13 at 9:36 AMProactive research analyst on Shield Therapeuticsproactiveinvestors.com - December 14 at 8:28 AMShield Therapeutics completes fundraiseproactiveinvestors.com - December 14 at 8:28 AMShield Therapeutics secures £15.1m in raise and seals deal with healthcare companymsn.com - December 13 at 5:26 PMShield Therapeutics agrees US partnership to promote Accrufer, launches equity fundingproactiveinvestors.com - December 13 at 6:36 AMShield Therapeutics’ lead product Accrufer expected to gain Korean regulatory approval in 2023proactiveinvestors.com - October 31 at 7:24 AM Get Shield Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. STX Media Mentions By Week STX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STX News Sentiment▼-0.150.42▲Average Medical News Sentiment STX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STX Articles This Week▼40▲STX Articles Average Week Get Shield Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CHLL News Today MXC News Today INHC News Today PRM News Today ABDX News Today BVX News Today TLY News Today IMM News Today POLX News Today SNG News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:STX) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shield Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
